Canakinumab for the management of pyoderma gangrenosum: a case series of two patients and literature review
Aims To evaluate the efficacy and adverse events of canakinumab in the treatment of pyoderma gangrenosum (PG).Methods We report two cases of refractory PG treated with canakinumab after failing multiple therapies.Results A 44-year-old female achieved complete ulcer resolution after 31 months of cana...
Saved in:
| Main Authors: | Howard Jie Yang, William Spratt, Francis Yi Xing Lai, Senhong Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2495834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upadacitinib Monotherapy for Treatment of Pyoderma Gangrenosum
by: Mohamad R. Taha, et al.
Published: (2025-12-01) -
Pyoderma gangrenosum: update and guidance
by: Luiz Felipe Duarte Fernandes Vieira, et al.
Published: (2022-12-01) -
Living with Pyoderma Gangrenosum: A Qualitative Study
by: Jacqueline Jiang, et al.
Published: (2024-12-01) -
A Case of Pyoderma Gangrenosum on the Lip
by: Mari Nakanishi, et al.
Published: (2025-04-01) -
Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
by: Paweł Głuszak, et al.
Published: (2025-02-01)